ISRCTN59071456已完成不适用
O BLEeding excess with antiplatelet treatment with thromboserin during coronary artery bypass grafting (CABG)
Imperial College London (UK)0 个研究点目标入组 120 人开始时间: 2010年7月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The original protocol, which received ethical and MHRA approval states. All patients requiring cardiac surgery.
排除标准
- •The original protocol, which received ethical and MHRA approval states.
- •Patients with bradycardia or bradyarrhythmia, unless drug induced and the drug stopped (e.g. ß- adrenoreceptor antagonists).
- •Patients treated with serotonin re-uptake inhibitors.
研究者
相似试验
进行中（未招募）
不适用
ACUTE-PRASJPRN-jRCTs031220079Fujimoto Shigeru200
已完成
不适用
The effect of continuation of anti-platelet agents on bleeding complications after dento-alveolar surgical proceduresISRCTN54741248Academic Medical Centre (AMC) (Netherlands)145
已完成
不适用
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery DiseaseJPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
进行中（未招募）
不适用
Effect of three different ticagrelor loading dose formulations (crushed, chewed or intact tablets) on the degree and rapidity of platelets ability to clump together and form clots in patients with stable angina referred for coronary angiographyEUCTR2014-002227-96-SECounty Council of Östergötland
已完成
不适用
Antiplatelet therapy in endovascular treatment for intracranial aneurysms, a multi center cohort study (APT-ANswer study)JPRN-UMIN000044122Gifu University500